What OTC Glucose Monitors Are—and Why Dexcom Stelo Matters
Over-the-counter continuous glucose monitors are wearable health tracking devices that measure glucose through a small sensor under the skin and send readings to a connected app, giving users frequent, app-based feedback on how food, activity, and daily routines affect glucose patterns without requiring a traditional prescription or fingerstick meter. Dexcom Stelo clearance is a turning point: the FDA has cleared the Stelo Glucose Biosensor System for adults and for people 2 years and older who do not use insulin, making it the first OTC continuous glucose monitoring system cleared for both adults and children who are not on insulin therapy. Stelo pairs a disposable sensor worn on the body with a smartphone app that displays glucose values and trends about every 15 minutes. Unlike prescription-only diabetes management devices that can dose insulin or alarm for lows, OTC glucose monitors are designed as feedback tools rather than full treatment systems.
Who Gains the Most: Diabetes, Prediabetes, and Wellness Users
OTC glucose monitors like Stelo and Abbott’s Lingo sit at the intersection of diabetes management devices and consumer wellness tools. Their clearest benefits show up for people with prediabetes or some people with diabetes who do not use insulin and want better visibility into daily glucose swings. A continuous glucose monitoring system can display how meals, exercise, or poor sleep affect glucose in near real time, helping users fine-tune routines between clinic visits. According to the CDC’s 2026 National Diabetes Statistics Report, 115.2 million adults have prediabetes and 40.1 million people have diagnosed or undiagnosed diabetes, which gives OTC CGMs a large potential user base. A 2026 systematic review found that CGM use lowered mean glucose in non-diabetic users, with the effect concentrated in people with prediabetes, while finding no significant impact on BMI. For healthy, wellness-curious users, the feedback can be engaging but the long-term clinical payoff is still uncertain.
Pediatrics, Caregivers, and Schools: New Rules for a Connected Device
When Dexcom Stelo gained pediatric clearance for users 2 years and older who do not use insulin, glucose tracking moved into a complex environment of phones, apps, and classroom rules. Stelo is not a standalone meter; it relies on a compatible smartphone or smart device to display values, and a smartwatch can only act as an extension when it stays paired and within range of the phone. For children, Stelo must be used under adult caregiver supervision, and caregivers can receive data on their own phones. This raises practical questions: can caregiver-connected phones remain on during class, do school Wi-Fi and device rules allow the app to work, and who is responsible for responding to glucose patterns during the school day? Health teams also need screening processes, because OTC status does not make Stelo suitable for children who use insulin, have problematic hypoglycemia, or need real-time low-glucose alerts.
Apps, Data, and the Blurry Line Between Medical and Lifestyle Tech
Every OTC continuous glucose monitoring system comes with more than a sensor: users also get an app, a cloud account, and often coaching features that turn raw readings into color-coded graphs, trends, and recommendations. This has made OTC glucose monitors feel like other wearable health tracking tools, even though they are medical devices with FDA clearance. HIPAA protections apply when data flows through covered entities such as health care providers, but many direct-to-consumer health apps and wellness platforms fall outside that framework and may instead be covered by rules like the FTC’s Health Breach Notification Rule. Users need to read data policies carefully: some apps may use glucose data for analytics, product research, or third-party integrations. Meanwhile, FDA guidance for cyber devices highlights the need for security planning, but no amount of encryption turns a feedback app into formal medical advice. The takeaway: treat OTC CGM data as informative, not as a replacement for a clinician’s judgment.
Should You Wear an OTC CGM?
For many people with prediabetes or non–insulin-treated diabetes, OTC glucose monitors can be a practical extension of existing care, helping them see day-to-day patterns between lab visits. For caregivers of children who qualify, they add visibility but also demand clear plans about supervision, school policies, and who responds to app alerts or trends. For healthy users chasing optimization, the value is murkier: short-term spikes do not always signal disease, and a month of colorful charts does not guarantee better long-term health. Unlike smartwatches or rings that claim noninvasive glucose readings without piercing the skin—devices the FDA has warned consumers not to use for blood glucose measurement—Stelo and Lingo are cleared medical products. The smartest approach is to confirm that any sensor is FDA cleared, understand what the app does with your data, and involve a health care professional before changing medication or major routines based on OTC glucose readings.
